Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus

American Heart Journal

Volumn 155, Issue 2, 2008, Pages 284-289

  Porter, Avital ^a   Assali, Abid R ^a   Zahalka, Abed ^a   Iakobishvili, Zaza ^a   Brosh, David ^a   Lev, Eli I ^a   Mager, Aviv ^a   Battler, Alexander ^a   Kornowski, Ran ^a   Hasdai, David ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 38149123993     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.010     Document Type: Article

References (40)

1. Choi K.M., Lee K.W., Kim S.G., et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 90 (2005) 175-180
2. Foo K., Cooper J., Deaner A., et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89 (2003) 512-516
3. Strades I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Inten Med 64 (2004) 982-988
4. Ainla T., Baburin A., Teesalu R., et al. The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med 22 (2005) 1321-1325
5. Straumann E., Kurtz D.J., Muntwyler J., et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 150 (2005) 1000-1006
6. Kosuge M., Kimura K., Kojima S., et al. Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 69 (2005) 375-379
7. Nak K.H., Mah P.K., Tey B.H., et al. Fasting blood sugar level: a determinant for in-hospital outcome in patients with first myocardial infarction and without glucose intolerance. Ann Acad Med Singapore 22 (1993) 291-295
8. Suleiman M., Hammerman H., and Boulos M. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction. Circulation 111 (2005) 754-760
9. Dibra A., Ndrepepa G., Mehilli J., et al. Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary intervention. Am J Cardiol 96 (2005) 1113-1115
10. Lavi S., Kapeliovich M., Gruberg L., et al. Hyperglycemia during acute myocardial infarction in patients who are treated by percutaneous coronary intervention: impact on long-term prognosis. In J Cardiol (2007) Epub ahead of print
11. Halkin A., Singh M., Nikolsky E., et al. Prediction of mortality after primary percutaneous intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45 (2005) 1397-1405
12. Buffon A., Biasucci L.M., Liuzzo G., et al. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
13. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
14. Taubert G., Winkelman B.R., Schleiffer T., et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145 (2003) 285-291
15. Lankisch M., Futh R., Schotes D., et al. High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol 95 (2006) 80-87
16. Tenerz A., Norhammer A., Silveira A., et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 26 (2003) 2770-2776
17. Aguilar D., Solomon S.D., Kober L., et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 110 (2004) 1572-1578
18. Goyal A., Mahaffey K.W., Garg J., et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27 (2006) 1289-1297
19. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 47 (2006) 236-265
20. Stranders I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
21. Kosiborod M., Rthore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
22. 1c in acute myocardial infarction. Diabet Med 21 (2004) 305-310
23. Husband D.J., Alberti K.G., and Julian D.G. "Stress" hyperglycemia during acute myocardial infarction: an indicator of pre-existing diabetes?. Lancet 2 (1983) 179-181
24. Tenerz A., Nilsson G., Forberg R., et al. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Int Med 254 (2003) 494-503
25. Ishihara M., Inoue I., Kawagoe T., et al. Is admission hyperglycemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J 27 (2006) 2413-2419
26. Oswald G.A., Smith C.C., Betteridge D.J., et al. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. BMJ 293 (1986) 917-922
27. Oswald G.A., Smith C.C., Delamothe A.P., et al. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 59 (1988) 663-671
28. Calles-Escandon J., and Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22 (2001) 36-52
29. Aronson D., Ryfeld E.J., and Chesebro J.H. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Int Med 126 (1997) 296-306
30. Ishihara M., Inoue I., Kawagoe T., et al. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with an anterior wall first acute myocardial infarction. Am J Cardiol 92 (2003) 288-291
31. Kesrsten J.R., Montgomery M.W., Ghanssemi T., et al. Diabetes and hyperglycemia impair activation of mitochondrial KATP channels. Am J Physiol Heart Circ Physiol 280 (2001) H744-H750
32. Scechter M., Merz N.B., Labrador P.-M.J., et al. Blood glucose and platelet-dependent thrombosis in patients with acute coronary artery disease. J Am Coll Cardiol 35 (2000) 300-307
33. Marfella R., Esposito K., Giunta R., et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 101 (2000) 2247-2251
34. Tile L.M., Cummings P.M., Giddens K., et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 1012 (2000) 2247-2251
35. Kersten J.R., Toller W.G., Tessmer J.P., et al. Hyperglycemia reduces coronary blood flow through a nitric oxide-mediated mechanism. Am J Physiol Heart Circ Physiol 281 (2001) H2097-H2104
36. Capes S.E., Hunt D., Malmberg K., et al. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: a systemic overview. Lancet 355 (2000) 773-778
37. Wahab N.N., Cowden E.A., Pearce N.J., et al. On behalf of the ICONS investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
38. Sranders I., Diammant M., van Gelder R.E., et al. Admission blood glucose levels as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Int Med 164 (2004) 982-988
39. Wong V.W., Ross D.L., Park K., et al. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabet Res Clin Pract 64 (2004) 85-91
40. Metha R.H., Harjai K.J., Cox D., et al. primary angioplasty in myocardial infarction (PAMI) investigators. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 42 (2003) 1739-1746